Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily LLY Bull 2X Shares

25.42
+1.114.59%
Post-market: 25.41-0.0100-0.04%19:57 EST
Volume:107.09K
Turnover:2.72M
Market Cap:15.25M
PE:- -
High:26.30
Open:24.47
Low:24.14
Close:24.31
52wk High:34.28
52wk Low:11.50
Shares:600.00K
Float Shares:600.00K
Volume Ratio:0.33
T/O Rate:17.85%
Dividend:3.09
Dividend Rate:12.14%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
7 hours ago

Eli Lilly & Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
7 hours ago

Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision

Reuters
·
8 hours ago

Eli Lilly: Expect Medicare Beneficiaries Will Have Access to Discounted Lilly Obesity Medicines by July 1, 2026

THOMSON REUTERS
·
10 hours ago

Eli Lilly: Pre-Launch Inventories Capitalized as of Dec 31, 2025 Were $1.5 Bln, Primarily Related to Orforglipron- SEC Filing

THOMSON REUTERS
·
10 hours ago

Eli Lilly posts FY 2025 net income of USD 20.64 billion, up nearly double

Reuters
·
10 hours ago

Eli Lilly Stock (LLY) Gets New ‘Buy Rating’ After Strong Earnings

TIPRANKS
·
13 hours ago

BUZZ-Jefferies lifts Novo Nordisk to 'hold,' sees downside risks now priced in

Reuters
·
Yesterday

Novo Nordisk plans to launch Wegovy vials

Reuters
·
Yesterday

Merck & Co. Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds

Reuters
·
Yesterday

CICC Adjusts Price Target on Eli Lilly and Co. to $1,107 From $1,060, Maintains Neutral Rating

MT Newswires Live
·
Feb 11

Eli Lilly's Intestinal Disease Treatment Mirikizumab Receives Approval in China

Stock News
·
Feb 11

Eli Lilly: Mirikizumab Approved in China for Treatment of Moderate-to-Severe Crohn's Disease and Ulcerative Colitis - Co Statement

THOMSON REUTERS
·
Feb 11

Fisher Asset Management Boosts Eli Lilly Stake by 153K Shares

TIPRANKS
·
Feb 11

Eli Lilly Expands Genetic Medicines Pipeline And Valuation Case With New Deals

Simply Wall St.
·
Feb 11

Gilead's Earnings Surprise. HIV Drug Sales Were Strong. -- Barrons.com

Dow Jones
·
Feb 11

Taking the new Wegovy pill every day is really complicated. Will patients stick with it?

Dow Jones
·
Feb 11

Eli Lilly upgraded to Buy from Hold at Freedom Capital

TIPRANKS
·
Feb 11

Eli Lilly’s Solbinsiran Trial Advances in High-Risk Cholesterol Market

TIPRANKS
·
Feb 11